Author

Ijeoma Ogbuehi

Observed name: Ogbuehi Ijeoma

Institution: University of Alberta

Observed institutions: University of Port Harcourt, University of Alberta

OpenAlex ID: A5086783291

Tenofovir Renal Toxicity: Evaluation of Cohorts and Clinical Studies—Part 2

2014 · Adikwu Elias, Ogbuehi Ijeoma, et al. · Pharmacology &amp Pharmacy · 17

Tenofovir Renal Toxicity: Evaluation of Cohorts and Clinical Studies—Part One

2013 · Adikwu Elias, Ogbuehi Ijeoma, et al. · Pharmacology &amp Pharmacy · 15

A phase 1 randomized controlled trial of a peptide-based group A streptococcal vaccine in healthy volunteers

2024 · Vanessa Meier-Stephenson, Michael T. Hawkes, et al. · Trials · 12

Human Antibodies to M-Protein Epitope-Based Vaccines Demonstrate Increased Immunogenicity and Streptococcus pyogenes (StrepA) Bactericidal Activity

2025 · Christie T. M. Short, Vanessa Meier-Stephenson, et al. · 1

Safety and immunogenicity of novel group A streptococcal peptide vaccines targeting cryptic epitopes (J8-K4S2 and P*17-K4S2): a first-in-human, double-blinded, phase 1 randomised controlled trial

2026 · Vanessa Meier-Stephenson, Manisha Pandey, et al. · Research Square

Phase I Trial of a Peptide-Based Vaccine to Prevent Group A Streptococcal Infection

2025 · Michael F. Good, Manisha Pandey, et al.

Risk Assessment of Co-treatment With Rifampicin and Tenofovir on Renal Function of Male Albino Rats

2016 · Elias Adikwu, Ijeoma Ogbuehi · The African Journal of Pharmacology and Therapeutics

Works count: 7

Citation count: 45

H-index: 3

I10-index: 3